Dr RR Baliga's "Got Knowledge Doc" Podkast

Friedrich Nietzsche challenged the modern mind to think bravely, live honestly, and create meaning rather than inherit it 🧠⚡ From "God is dead" to self-overcoming, his ideas push us to confront nihilism and affirm life with courage and creativity 🔥🎭 More than a philosopher, Nietzsche remains a provocation—asking each of us: what values will you create? 🚀📚

Did you know the fat around our arteries is more than just padding? 🧬🩺 Recent findings show that deleting PRDM16 in perivascular adipose tissue transforms protective beige fat into fibrotic tissue, upregulating QSOX1 and driving hypertension 🩸📈. Activating brown fat or targeting QSOX1 could offer novel therapies. As internists, staying curious about adipose–vascular cross-talk might reshape how we tackle hypertension. 💡🔥 #Cardiology #InternalMedicine #Hypertension"

🧬🧠❤️ The Immune System Is Not Just Defense — It Is Physiology A superb Science Review (Nahrendorf, Ginhoux, Swirski, 2025) reframes immunity as a systems integrator, shaping brain function, heart rhythm, metabolism, pregnancy, and tissue repair—quietly maintaining homeostasis across the lifespan. Immune cells are not visitors; they are residents, communicators, and regulators in every organ system. 🧩 Defense meets regulation. 🧩 Immunology meets physiology. 📖 Science, August 2025 — a must-read for clinicians, physiologists, and systems thinkers.

🧬💥 New cardio-oncology insight: DNA-damaging chemotherapy (highlighting carboplatin) can reprogram the heart's immune "resident staff"—specifically CCR2− cardiac-resident macrophages—followed by monocyte-driven repopulation that looks "resident-like." 🫀🛡️ In a mouse model, this post-chemo macrophage landscape was linked to less adverse remodeling after hypertensive stress (AngII/PE), with reduced fibrosis and cardiomyocyte hypertrophy and lower remodeling gene signals. 📉🔬 Take-home: beyond myocytes, chemotherapy may shift the cardiac immune baseline that shapes later injury responses—an underappreciated axis for survivorship risk (and resilience). ✅ #CardioOncology #Chemotherapy #Immunology #Macrophages #HeartFailure #CancerSurvivorship #PrecisionMedicine

🧠💧 How does the brain clean itself—and defend itself? A landmark Neuron review unifies two once-separate stories: brain waste clearance and immune surveillance. The glymphatic system, powered by CSF flow, sleep, and vascular pulsatility, works hand-in-glove with meningeal lymphatics to clear toxins (β-amyloid, tau) and present brain antigens to the immune system. 💤 Sleep is not rest—it's maintenance. 🛡️ Clearance is not plumbing—it's immunity in motion. 🧠 When this system falters, neurodegeneration follows. A must-read for anyone interested in sleep, Alzheimer's disease, neuroimmunology, and brain health. 📘 Neuron, 2025.

🏆 How do world-class performers really develop? A fascinating Science review (Güllich et al., 2025) overturns a deeply held belief: early stars are rarely future legends. Across sports, science, music, and chess, peak performers often showed slower early progress, less early specialization, and more multidisciplinary practice. The lesson is lyrical in its simplicity: breadth before depth, patience before acceleration. For educators, mentors, and institutions, this challenges how we identify talent and design training—short-term brilliance may come at the cost of long-term greatness. 📖 Science (2025): Recent discoveries on the acquisition of the highest levels of human performance

🏃‍♀️ Exercise is not lifestyle advice—it's cancer biology. A landmark analysis of 443,768 adults from the UK Biobank and NHANES shows that regular aerobic physical activity (≈117–500 min/week) is associated with: • 21% lower risk of inflammation-related cancers • 34% lower all-cancer mortality Mechanistically, exercise: 🔬 Reduces chronic low-grade inflammation 🧬 Reverses immunosenescence (↓ Mki67⁺ immune cells) 🛡️ Expands functional innate and adaptive immunity Strikingly, the mortality benefit rivals—or exceeds—that of many modern anticancer therapies. 📖 Jin et al., Cell Reports Medicine, 2025 In the era of sedentary epidemics, movement may be our most scalable precision therapy. #CancerPrevention #PhysicalActivity #Immunosenescence #Inflammaging #ExerciseIsMedicine #Aging #Oncology #PublicHealth

🫀 Europe puts the heart first. The EU Safe Hearts Plan is a bold, evidence-based roadmap to tackle Europe's leading cause of death—cardiovascular disease—through prevention 🛡️, early detection 🔍, better treatment 🏥, smart digital tools 🤖, and a relentless focus on equity ⚖️. With clear targets (including a 25% reduction in premature cardiovascular mortality by 2035 🎯), this plan signals a shift from reactive care to lifelong, personalized, and data-driven heart health—for every citizen, in every region. Strong hearts. Smarter systems. A healthier Europe. ❤️🇪🇺

🧠🦠 Why does abdominal pain affect women more? Science offers a cellular answer. A new Science study uncovers an estrogen-tuned gut pain circuit in which peptide YY–secreting enteroendocrine cells activate serotonin-releasing cells, sensitizing gut sensory nerves—especially in females. Hormones, microbes, and diet converge locally in the colon to amplify visceral pain, offering a biologically grounded explanation for menstrual-cycle variability and female-predominant disorders like irritable bowel syndrome. 📖 Venkataraman et al., Science (Dec 2025) Precision medicine begins by taking sex seriously.

📚🇩🇰 Søren Kierkegaard (1813–1855): the philosopher of choice, anxiety, and becoming Kierkegaard argued that the highest human task isn't just knowing the good—it's embodying it: becoming a self through commitment, responsibility, and inwardness. His framing of "existence" as the lived work of becoming helped spark what we now call existentialism. 🧭✨ In health care, his lens feels especially modern: moral distress, burnout, and "decision-fatigue" often intensify when we drift into autopilot—or when we outsource conscience to the "crowd." Kierkegaard's counter is tough-love and oddly hopeful: choose deliberately, live authentically, and let anxiety be a signal of freedom—not a verdict

🧬 When immunity saves—and harms—at the same time A striking NEJM correspondence reveals that patients receiving immune checkpoint inhibitors often sustain molecularly detectable multiorgan damage—weeks to months before symptoms appear. Using cell-free DNA methylation mapping, investigators show that immune-related adverse events are systemic, not isolated organ toxicities—the visible clinic finding is just the tip of the iceberg 🧊🧬 This work reframes irAEs as a global loss of immune tolerance and opens the door to early, molecular surveillance—particularly relevant for cardio-oncology and precision medicine. 📍 Source: The New England Journal of Medicine, December 2025 #Immunotherapy #CardioOncology #PrecisionMedicine #cfDNA #NEJM #TranslationalScience

🍷⏳ Why Hangovers Get Worse as We Age — Science, Not Sentiment Ever wondered why the same drink that once sparkled now punishes? A Well Informed piece from The Economist explains how aging physiology—less body water, slower metabolism, disrupted sleep, and toxic metabolites—turns modest indulgence into a morning reckoning. 🧠💤☠️ The takeaway is not abstinence, but wisdom: sip slowly, hydrate deliberately, respect sleep, and never underestimate biology. Aging, like good scholarship, rewards those who read the fine print. 📖🍸

🧬✨ Can we make the ageing immune system young again? A fascinating Nature study shows that a three-part mRNA cocktail (DFI) can temporarily rejuvenate T cells in aged mice, improving responses to vaccines and cancer immunotherapy—without breaking immune tolerance. By turning the liver into a short-term factory for key immune signals (DLL1, FLT3L, IL-7), the authors demonstrate that immune ageing is modifiable, not fixed. This elegant work—covered by Heidi Ledford in Nature—opens provocative questions about immune resilience, ageing biology, and the future of mRNA beyond vaccines. 🧠🛡️ 📄 Friedrich MJ et al., Nature 2025 | News & Views: Ledford H. 🔗 doi:10.1038/s41586-025-09873-4 | doi:10.1038/d41586-025-04082-5

🧬 Protein Restriction, Aging, and Longevity ⏳ A remarkable new study in Cell shows that moderate protein restriction—especially when started in midlife—can reprogram aging biology across 41 organs, improving metabolic and cardiovascular health. 🫀⚙️ Using deep multi-organ proteomics in mice and human plasma validation, the authors demonstrate benefits mediated through ↓ IGF-1, ↓ mTOR, ↑ AMPK, and activation of brown adipose tissue. Importantly, the data also caution that extreme protein restriction may provoke inflammation, underscoring that moderation matters. ⚠️🎯 A powerful example of how nutrition shapes the biology of aging—organ by organ, pathway by pathway. 📖 Cell (2025) #Aging #Longevity #ProteinRestriction #MetabolicHealth #CardiovascularHealth #Proteomics #PrecisionNutrition

🧬 Rethinking Neutrophils: From Lone Cells to Living Systems 🧠⚔️ For over a century, neutrophils were seen as short-lived foot soldiers of immunity. This new Cell review reframes them as something far more interesting: a coordinated, adaptive collective. ✨ Key ideas: • Short-lived cells, long-term memory • Two compartments: granulopoietic + mature • Plastic, circadian, tissue-adaptive behavior • Major implications for inflammation, cancer, and immunotherapy A powerful example of how systems thinking can transform classical immunology. 📖 Worth a deep read: The Neutrophil Collective — Cell (2025) #Immunology #Neutrophils #InnateImmunity #SystemsBiology #CancerImmunology #MedicalEducation #TranslationalScience

⏰🫀 Does the heart care about the time of day? Yes—profoundly. A new study in the Journal of Experimental Medicine reveals a circadian checkpoint in neutrophils that determines how much damage occurs after myocardial infarction. Morning ischemia triggers more injury, while nighttime CXCL12–CXCR4 signaling reprograms neutrophils, relocating them into the infarct core and sparing healthy myocardium—without impairing antimicrobial defense. 🌙🧬 This work reframes infarct biology from how much ischemia to when it happens and opens the door to chronotherapy for cardiovascular disease. Timing, it seems, is tissue. 🕰️✨

Exploring Hegel's Vision of Progress and Freedom 🌍🔄✨ Reflecting on Georg Wilhelm Friedrich Hegel's remarkable insight that history is a dynamic journey toward greater human freedom. His dialectical lens — the idea that contradictions are not dead ends but engines of development — offers a powerful way to think about institutions, leadership, and change. 🔍💡 From Phenomenology of Spirit to Philosophy of Right, Hegel challenges us to see ourselves as part of a larger unfolding story where reason, community, and ethical life evolve together. His work continues to influence modern political thought, social theory, and the way we understand progress itself. 📚🌱 A timely reminder: growth often emerges through tension, dialogue, and transformation — not avoidance. #Hegel #Philosophy #GermanIdealism #Leadership #History #Ethics #IntellectualLeadership #Progress

🫀🧬 Cardio-Oncology: where modern cancer cures meet the heart As cancer survival improves, cardiovascular toxicity has emerged as a defining challenge of our time. From BTK inhibitor–associated atrial fibrillation ⚡, to immune checkpoint inhibitor myocarditis 🔥, to VEGF-driven hypertension 🩸, the heart increasingly pays the price of precision oncology. This FAQ-driven, clinician-ready Cardio-Oncology resource, grounded in the 2025 ACC Concise Clinical Guidance published in the Journal of the American College of Cardiology (JACC), translates complexity into clarity—highlighting permissive cardiotoxicity, multidisciplinary care 🤝, and practical decision-making that protects both survival and the heart ❤️. Because in modern medicine, we should never have to choose between curing cancer and caring for the heart.

🧬 Prediabetes remission is not just metabolic—it's cardiovascular medicine. ❤️ A new analysis in The Lancet Diabetes & Endocrinology shows that achieving remission to normoglycaemia—not merely delaying diabetes—was associated with a ~50% reduction in cardiovascular death or heart failure hospitalisation, with benefits persisting for 20–30 years across U.S. and Chinese cohorts ⏳📉. 🔍 The message is profound and practical: normalize glucose early, protect the heart long-term. Remission may represent a measurable, durable, and globally applicable prevention target, alongside weight loss and lifestyle change. This is prevention with a memory—and a legacy. 🧠❤️

🔬 New Insights on MASLD from JAMA 🍃 I recently reviewed an excellent JAMA article on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)—now recognized as the most common chronic liver disease worldwide. The review highlights how metabolic dysfunction, inflammation, and fibrosis converge to drive long-term risks, including cardiovascular disease, hepatocellular carcinoma, and extrahepatic cancers. Key advances include better noninvasive fibrosis assessment (FIB-4, elastography), strong evidence for lifestyle-driven weight loss, and new therapeutic momentum with resmetirom and semaglutide for MASH with fibrosis. As MASLD incidence accelerates globally, this synthesis underscores the urgency of early detection, metabolic risk control, and multidisciplinary care. 🌍💡

In this week's exploration, I dive into the brain's hidden "plumbing"—the glymphatic and meningeal lymphatic systems—drawing from a remarkable report in Science magazine (Dec 2025). The piece outlines emerging Alzheimer's strategies ranging from VEGF-C and Aquaporin-4 gene therapy to vasomotion drugs, CO₂ breathing, massage-based lymphatic stimulation, and even experimental lymphovenous surgery. A quiet revolution is underway—hope flowing through the brain's deepest channels. 💧🌊 #Neuroscience #Alzheimers #ScienceMagazine #BrainHealth

🌍 New WHO Guidance on GLP-1 Therapies: A Turning Point in Obesity Care 💉📘 The latest JAMA report highlights a pivotal moment in global health: the WHO's evidence-informed guideline on GLP-1 therapies for adults living with obesity. With over 1 billion people affected worldwide, this chronic, relapsing disease demands integrated, equitable, lifelong care. The guidance underscores two essentials: 💊 Long-term GLP-1 therapy for those living with obesity 🤝 Intensive behavioral support to amplify and sustain benefits But the message is clear—medication alone is not enough. True progress requires strong health systems, equitable access, and person-centered prevention and care. A timely call to action for clinicians, policymakers, and health leaders everywhere. 🌱🌐

Delving into the latest JAHA review on immune checkpoint inhibitors and the heart has been illuminating 🔍❤️. As immunotherapy transforms cancer care, we're learning that unleashed T-cells can also stir the silent storms within vulnerable plaques ⚡🩺. This piece beautifully unpacks how ICIs may accelerate atherosclerosis, heighten ACS risk, and challenge our diagnostic instincts—especially when myocarditis and ischemia mimic one another 🎯🧬. As we push the frontier of cancer survival, cardio-oncology must rise in parallel: better surveillance, smarter risk reduction, and deeper mechanistic insight 🚀📚. A timely reminder that curing cancer and protecting the heart must go hand in hand 🤝❤️‍🔥.

Immanuel Kant: The Architect of Modern Reason 🧠✨ Fascinating to revisit Kant's legacy — the thinker who reshaped how we understand knowledge, morality, and human freedom. His ideas on autonomy, duty, and the categorical imperative continue to guide ethical reasoning in science, leadership, and society. From Critique of Pure Reason to Perpetual Peace, Kant invites us to think boldly: What can I know? What should I do? What may I hope? 🌍📚 His work still challenges us to act with integrity, respect human dignity, and build a more rational and just world. #Kant #Enlightenment #Ethics #Reason #Leadership #Philosophy 🕊️

🚀 Immune checkpoint inhibitors have transformed cancer care—but they come with a cardiovascular shadow. A new International Cardio-Oncology Society (IC-OS) position statement offers the clearest guidance yet on myocarditis, pericarditis, arrhythmias, ACS, and noninflammatory HF linked to ICI therapy. 🫀💡 Key insights include: • Early recognition with troponin, ECG, and CMR 🧪📊 • Smoldering vs. nonsevere vs. fulminant myocarditis distinctions 🔍 • Steroid-first management and the evolving role of abatacept + JAK inhibitors 💊 • Nuanced approaches to ICI rechallenge when cancer control demands it 🔄🎯 • The essential role of multidisciplinary cardio-oncology teams 🤝 This is a must-read for anyone navigating the intersection of oncology, cardiology, and immunotherapy. 🌐🔥

Chronic kidney disease now affects nearly 850 million people worldwide, yet early detection and simple, evidence-based interventions can dramatically change the trajectory of both kidney and cardiovascular health. 🌍🩺 The latest Lancet Seminar highlights powerful tools—eGFR + albuminuria staging, SGLT2 inhibitors, RAS blockade, statins, and GLP-1 therapies—that allow every clinician to make a measurable impact. 💊📉 A reminder that timely action is kidney protection. 💧✨

🚀 New insights from Cell shine a light on an unexpected ally in the fight against cognitive decline. A natural experiment from Wales shows that the shingles (herpes zoster) vaccine doesn't just prevent viral reactivation—it may also reduce new mild cognitive impairment and lower dementia-related mortality over long-term follow-up. 🔍 Using a strict birthday-based eligibility cutoff, the study provides causal evidence—rare in population dementia research—that vaccination may slow disease across its entire course. 🧠✨ As we rethink neuroinflammation, immunosenescence, and healthy aging, this work opens the door to exploring broader neuroprotective effects of adult vaccines. 📄 A reminder that sometimes the smallest public health interventions carry the biggest, most surprising benefits.

📘 New NEJM Evidence for the 2025–26 Vaccine Season is out—and it delivers clarity at a time we need it most. The systematic review of 511 studies shows strong, consistent protection against hospitalization from Covid-19, RSV, and Influenza, with reassuring safety profiles across age groups. 💉🛡️ Key insights: improved VE for updated Covid-19 strains, high efficacy of maternal RSV vaccination and nirsevimab for infants, and solid influenza performance. 📊👶 A valuable guide for clinicians, health systems, and policymakers as we prepare for the upcoming respiratory season. 🌐🏥

New Lancet Seminar on heart failure with reduced ejection fraction. 💓📘, this videocast walks listeners through the essentials of diagnosis, natriuretic peptides, imaging pathways, and the four foundational therapies shaping modern heart failure care. It's a clear, evidence-driven journey—designed to inform, clarify, and elevate bedside practice. Tune in to explore the science, the strategy, and the future of treating HFrEF. 🫀🔬✨ 🫀🔬✨

🔍💓 Chronic Coronary Artery Disease: Seeing What Matters Before It Hurts Just finished reviewing the 2025 Lancet paper on contemporary non-invasive imaging for chronic CAD, and the message is striking: how we see the heart shapes how well we save it. From CT angiography that unmasks non-obstructive plaque 🖥️➡️🫀 to stress PET/CMR that maps true ischemia under load 💨📊, multimodality imaging is redefining diagnosis, risk, and long-term outcomes. The evidence is clear: better imaging leads to better prevention—and in many cases, fewer invasive procedures and fewer missed opportunities for early therapy. In an era of rising cardiometabolic risk, precision imaging isn't just a tool—it's a commitment to catching disease in its "quiet" phase and protecting patients long before symptoms speak. Science, clarity, prevention. 🔬✨❤️

Exploring David Hume 🧠✨ Just revisited David Hume's extraordinary contributions to modern thought — a reminder of how deeply empiricism, skepticism, and the science of human nature shape our intellectual world. His insights on causation, the limits of reason, and the power of moral sentiment continue to resonate across philosophy, psychology, economics, and evidence-based decision-making. 🌍📚 Hume challenges us to look closely, question boldly, and reason with humility — a timeless guide for scholars, clinicians, and leaders navigating uncertainty. 🔍💡 #Philosophy #Hume #Empiricism #HumanUnderstanding #Enlightenment

The U.S. heart failure landscape is transforming—and fast. 🫀📊 A new JACC analysis reveals a 35-year shift from ischemic to metabolic drivers of heart failure, with obesity, dysglycemia, and chronic kidney disease rising sharply, even as blood pressure, cholesterol, smoking, and myocardial infarction decline. 📉⚖️ These trends demand a new generation of HF trials—more inclusive, prevention-focused, metabolism-centered, and designed to capture outcomes beyond cardiovascular death. 🚀🧬 A powerful reminder: heart failure is not inevitable—but the way we study and prevent it must evolve. 🌅💡

🧬⏳ New Insights into Organ-Specific Aging! 🧠❤️🩺 Just explored a remarkable Nature Aging study showing how organ-specific proteomic clocks can forecast disease, cognitive decline, and even longevity with impressive precision. These clocks—built from >2,900 plasma proteins—reveal that the brain, kidney, and arteries age on their own timelines, each carrying unique clues about future health. What struck me most is how brain aging outperforms traditional risk markers, predicting dementia even after accounting for age, APOE genotype, and cognitive scores. A powerful reminder that biological age isn't a single number—it's a symphony of organ-specific rhythms. 🎼 Exciting implications for precision medicine, early detection, and preventive cardiometabolic and neurodegenerative care. Science that helps us see aging not as fate, but as a map. 🗺️✨

Respiratory vaccines are not just infection-fighters—they're cardiovascular protectors. 💉🫀 The 2025 JACC Consensus reminds us that influenza, pneumococcal, COVID-19, RSV, and zoster vaccines reduce MI, HF decompensation, hospitalizations, and death in our most vulnerable patients. As clinicians, we hold the power to translate evidence into prevention: strong recommendations, simple pathways, and clear conversations can save lives long before interventions do. 🌟 Vaccinate to protect the heart. Shield to preserve life. Prevent to empower patients. ❤️‍🩹 #Cardiology #Vaccination #HeartHealth #JACC #Prevention #PublicHealth

The latest JAMA article on keratinocyte carcinomas 🌞—a timely reminder that BCC and cSCC remain the world's most common cancers, with more than 5.4 million cases annually in the US alone . The review highlights essential updates in epidemiology, high-risk features, prevention, and evidence-based management, especially the role of sun protection, actinic keratosis treatment, and risk-stratified surgical care 🔬⚕️. A great resource for clinicians committed to early detection, thoughtful treatment, and lifelong surveillance of at-risk patients 👀🛡️. If you work in dermatology, oncology, primary care, or population health, this is well worth your time 📚✨

🚨 Food Anaphylaxis: New Mechanisms Unveiled 🍽️🧬 A superb NEJM review highlights how cysteinyl leukotrienes act as gatekeepers in the gut—opening antigen passages, expanding mast cells, and amplifying the risk of oral anaphylaxis. The work elegantly bridges basic lipid biology with real-world food allergy challenges, and points toward new preventive strategies beyond current IgE-based therapies. 🔍 A must-read for clinicians, scientists, and anyone navigating severe food allergies.

🌿 What does the evidence really say about medical cannabis? A new JAMA review highlights a clear message: cannabis helps few conditions—and harms may outweigh benefits for many. 📉 Small benefit for nausea ⚡ Moderate benefit for select pediatric seizures 💊 Limited evidence for pain, insomnia, or psychiatric use ❤️ Risks rise with high-potency products, especially for heart and mental health. 🧭 Clinicians: guide with evidence, screen carefully, use lowest-risk options.

Thrilled to see a major step forward in dengue prevention! 🦟💊 A new NEJM study reports that daily mosnodenvir, a first-in-class antiviral targeting the NS3–NS4B interaction, significantly reduced DENV-3 viral load and prevented infection in a controlled human challenge model. 📉🧬 It's early, but the results offer real hope for a long-awaited oral dengue prophylaxis—with encouraging safety, strong PK, and dose-dependent efficacy. 🚀🌍 Exciting moment for global infectious-disease innovation and antiviral development. 🙌✨

Delighted to share a concise update on the latest NEJM review of Long QT Syndrome 🫀📘 — a masterful synthesis by Schwartz & Crotti that reframes how we recognize risk, personalize therapy, and prevent sudden death in this genetically mediated disorder. The piece highlights ion-channel biology, gene-specific triggers, the impact of modifier genes, and the effectiveness of a tiered therapeutic approach including beta-blockers, mexiletine, and left cardiac sympathetic denervation ⚡️🧬🛡️. For clinicians and trainees, it's a compelling reminder that precise diagnosis, careful QT interpretation, and yearly risk reassessment remain central to saving lives. Highly recommended reading for anyone involved in cardiac electrophysiology or inherited arrhythmia care 📚✨

🧠✨ Leibniz: Harmony, Logic, and the Birth of the Digital Mind Celebrating Gottfried Wilhelm Leibniz — the mathematician-philosopher who co-created calculus, invented binary arithmetic, and envisioned a world stitched together by pre-established harmony. His Monadology reads like proto-systems theory, and his binary system is the quiet ancestor of every computer we use today. For clinicians and scientists, his legacy whispers: 🔹 Seek the sufficient reason behind every pattern 🔹 Value multiple perspectives — every "monad" reflects a different truth 🔹 Build harmonies across disciplines, data streams, and patient narratives 🧩💡 From metaphysics to modern computing, he reminds us that insight deepens when logic meets wonder.

🧬 New insights into autism: A 2025 JCI Viewpoint highlights how hundreds of genes, polygenic risk, and specific environmental factors converge during fetal brain development to shape autism likelihood. 🧠 Early biomarkers—from infant MRI and ERPs to machine-learning models using EHR data—are accelerating earlier, more tailored interventions. 🌱 Advances in gene therapy, IGF-1 pathways, and proteomics offer emerging therapeutic possibilities. 🤝 Centering autistic voices remains essential as precision approaches evolve.

🔍 Peripheral Neuropathy: What Clinicians Should Know 🧠⚡ Peripheral neuropathy affects ~1% of adults worldwide, with diabetes accounting for more than half of all cases. The JAMA review highlights why length-dependent patterns dominate, how metabolic stress injures long axons first, and why sensory symptoms outpace motor loss. Evidence-based evaluation still begins with glucose testing, vitamin B12 with methylmalonic acid, and serum protein electrophoresis. First-line therapies for neuropathic pain — gabapentin, pregabalin, duloxetine, and tricyclics — offer meaningful but often incomplete relief, reminding us that prevention and risk factor modification remain central. A clear, elegant synthesis of mechanisms, diagnostics, and management — essential reading for anyone caring for patients with numbness, tingling, or burning feet. 👣✨

New NEJM insights on asymptomatic carotid stenosis 🧠🔍 The CREST-2 trials offer a landmark update: intensive medical therapy remains the cornerstone, while carotid stenting shows selective benefit when performed by expert operators. Endarterectomy, however, provides no significant advantage over modern medical management. With stricter blood-pressure and LDL targets, plus expanding use of PCSK9 inhibitors, the future of stroke prevention is increasingly precision-driven, medically optimized, and patient-centered. 💊📉✨ A thoughtful read for all involved in vascular care, cerebrovascular prevention, and clinical decision-making. 📘🫀

The new Lancet Series on ultra-processed foods offers a striking insight: as UPFs rise globally, traditional whole-food diets decline—bringing nutrient imbalance, overeating, toxic exposures, and hyper-palatable formulations that quietly reshape health trajectories. 🍔➡️⚠️ Across more than 100 prospective studies and multiple trials, higher UPF intake consistently links to obesity, type 2 diabetes, cardiovascular disease, kidney disease, depression, and higher all-cause mortality. 📉🩺 The message is clear: reducing UPF consumption isn't a wellness trend—it's a public health imperative. Evidence-based policies and renewed investment in minimally processed, culturally rooted food systems are urgently needed. 🌱🔬🌏 #UltraProcessedFoods #PublicHealth #Nutrition #ChronicDisease #LancetSeries

Home-delivered DASH-patterned groceries paired with dietitian counseling meaningfully lowered blood pressure and LDL cholesterol among Black adults living in food deserts 🥗📉—as demonstrated in the GoFresh randomized trial (JAMA). An accompanying editorial highlights why future "food-as-medicine" programs must prioritize underconsumed, health-promoting foods and align with modern evidence favoring higher-fat DASH/Mediterranean patterns 🌱🫒. A powerful reminder: the right groceries can be therapeutic.

🩺 New insights in hemodialysis care. A major New England Journal of Medicine study reports that daily supplementation with long-chain omega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid) led to a 43% reduction in serious cardiovascular events among adults receiving maintenance hemodialysis. 🐟💙 In a population where traditional cardioprotective therapies often fall short, these findings open a fresh path for investigation — and perhaps, future practice. 📉🔬 A confirmatory trial will be essential, but the signal is compelling. 🌅

🚀 A milestone moment in lipid therapeutics! The new JAMA trial on the oral PCSK9 inhibitor Enlicitide reports a ~60% reduction in LDL-C, with parallel decreases in ApoB and Lp(a)—all on top of maximally tolerated statin therapy. For individuals with heterozygous familial hypercholesterolemia (HeFH)—where reaching LDL targets remains a persistent challenge—this represents a major advance. An oral agent matching the potency of injectable PCSK9 inhibitors could reshape adherence, access, and long-term ASCVD prevention. 🌉💊 Safety was comparable to placebo, and effects were rapid, robust, and sustained to 52 weeks. The ongoing CORALreef Outcomes trial will determine its impact on major cardiovascular events. 🔬❤️ Innovation in lipid lowering is accelerating—and patient-centered options are expanding. #JAMA #LipidManagement #HeFH #CardiovascularHealth #PCSK9 #Enlicitide #Prevention 🌟

☕ DECAF Trial insight! A new JAMA study shows that daily caffeinated coffee may lower recurrence of atrial fibrillation compared with abstinence. Patients drinking ~1 cup/day had 47% recurrence vs 64% with abstinence (HR 0.61, p=0.01) 📉💓 No major safety concerns—challenging long-held beliefs that coffee is proarrhythmic. 💡Takeaway: For many patients with AF, enjoying their morning brew may be both safe and possibly beneficial. #AtrialFibrillation #Cardiology #JAMA #ClinicalTrials #HeartHealth ☕💓📊

🚨 New insights from The Lancet 🚨 A major individual-patient-data meta-analysis (6 RCTs, 8,836 patients) shows that complete revascularisation in acute myocardial infarction significantly reduces cardiovascular death, all-cause mortality, and recurrent MI. 💓📉 Benefits were consistent across age, sex, STEMI/NSTEMI, and lesion characteristics — strengthening the case for a more comprehensive approach beyond the culprit lesion alone. 🔬🩺 A powerful reminder: treating the whole heart saves more lives. ❤️✨

🧬 New NEJM data on Olezarsen! In patients with severe hypertriglyceridemia, monthly RNA-targeted therapy delivered major triglyceride reductions (−62% to −72%) and a significant drop in acute pancreatitis risk (rate ratio 0.15). ✨ Improvements extended to ApoC-III, remnant cholesterol, and non-HDL cholesterol, with consistent benefits across both CORE-TIMI trials. 💡 A promising step forward in precision lipid therapy and pancreatitis prevention.